Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CHORIONIC GONADOTROPIN FOR INJECTION, USP 10000 UNIT — DIN 02247459

CHORIONIC GONADOTROPIN : 10000 UNIT · FRESENIUS KABI CANADA LTD · POWDER FOR SOLUTION · wholesale supply in Canada

Health Canada status: MARKETED

What is CHORIONIC GONADOTROPIN FOR INJECTION, USP?

CHORIONIC GONADOTROPIN FOR INJECTION, USP 10000 UNIT contains CHORIONIC GONADOTROPIN : 10000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02247459, held by FRESENIUS KABI CANADA LTD, supplied as POWDER FOR SOLUTION for SUBCUTANEOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 13-Nov-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is CHORIONIC GONADOTROPIN FOR INJECTION, USP used for?

Chorionic Gonadotropin for Injection, USP is indicated for the treatment of Prepubertal Cryptorchidism, Delayed Adolescence, Dwarfism (pituitary), Hypogonadotropic Eunuchoidism, and Selected Cases of Hypogonadotropic Hypogonadism (hypogonadism secondary to a pituitary deficiency) in Males. For females, it is indicated for Ovulation Induction, Abortion (habitual), Infrequent Scanty Bleeding (functional), and Functional Sterility.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Is there a generic Chorionic Gonadotrophin in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

6 holders have a Canadian DIN containing Chorionic Gonadotrophin, across 6 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
FRESENIUS KABI CANADA LTD11CHORIONIC GONADOTROPIN FOR INJECTION, USPSourceable in Canada
ORGANON CANADA INC.11PREGNYLSourceable in Canada
AYERST LABORATORIES10APL INJ 1000 IU/MLNo marketed DIN
EMD SERONO, A DIVISION OF EMD INC., CANADA10PROFASI HP 10000No marketed DIN
PHARMASCIENCE INC10PROFASI HP INJ 10000UNIT/VIAL USPNo marketed DIN
WYETH-AYERST CANADA INC.10A.P.L. - PWS-LIQNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label10000 UNIT
Dosage formPOWDER FOR SOLUTION
RouteSUBCUTANEOUS ; INTRAMUSCULAR
Pack configuration (monograph)Each package contains one vial of Chorionic Gonadotropin for Injection, USP (10 000 USP units) and one 10 mL multiple-dose vial of Sterile Diluent (Bacteriostatic Water for Injection, USP containing 0.9% benzyl alcohol).
StorageChorionic Gonadotropin for Injection, USP sterile lyophilized powder should be stored at controlled room temperature (less than 25 °C) until the expiry date indicated on the label. When reconstituted, the solution should be kept refrigerated (2 °C to 8 °C) and should be used within 30 days.
Shipping classCold chain — validated shipper with temperature monitoring

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.

Substance and classification

Active substanceChorionic Gonadotrophin
ATC codeG03GA01
AHFS class68:18.00
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02247459
DIN (unpadded, as printed on some documents)2247459
Brand nameCHORIONIC GONADOTROPIN FOR INJECTION, USP
Generic / active ingredientCHORIONIC GONADOTROPIN : 10000 UNIT
Market authorization holderFRESENIUS KABI CANADA LTD
Health Canada scheduleSchedule D
ATC codeG03GA01
ATC anatomical main groupG — Genito-urinary system and sex hormones
ATC therapeutic subgroupG03GA
Current statusMARKETED
Status date13-Nov-2015
Original market date2004-09-13 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

2 of 6 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
PREGNYL10000 UNITPOWDER FOR SOLUTION ; KITORGANON CANADA INC.MARKETED02182904
A.P.L. - PWS-LIQ10000 UNITLIQUID ; POWDER FOR SOLUTIONWYETH-AYERST CANADA INC.CANCELLED POST MARKET02168936
APL INJ 1000 IU/ML1000 UNITLIQUIDAYERST LABORATORIESCANCELLED POST MARKET00002291
PROFASI HP 1000010 MLKIT ; POWDER FOR SOLUTION ; LIQUIDEMD SERONO, A DIVISION OF EMD INC., CANADACANCELLED POST MARKET01925679
PROFASI HP INJ 10000UNIT/VIAL USP10000 UNITPOWDER FOR SOLUTIONPHARMASCIENCE INCCANCELLED POST MARKET00598534

2 · Same class — other molecules in ATC G03GA

MoleculeCanadian brandsDINsMarketedSourceable
Follitropin AlfaGONAL-F · GONAL-F PEN103Yes
Follitropin DeltaREKOVELLE63Yes
CombinationsPERGOVERIS43Yes
Chorionic GonadotrophinA.P.L. - PWS-LIQ · APL INJ 1000 IU/ML · CHORIONIC GONADOTROPIN FOR INJECTION, USP · PREGNYL · +2 more62Yes
Choriogonadotropin AlfaOVIDREL22Yes
Follitropin BetaPUREGON · PUREGON (600 IU) · PUREGON 100 I.U. · PUREGON 50 I.U.61Yes
Human Menopausal GonadotrophinHUMEGON INJ 75 I.U. · MENOPUR · PERGONAL 75 I.U. · REPRONEX41Yes
UrofollitropinBRAVELLE · FERTINORM HP 150 - PWS DILUENT IM SC · FERTINORM HP 75 - PWS DILUENT IM SC · METRODIN 75 I.U.40Not in Canada
Lutropin AlfaLUVERIS10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC G03G

ATC subgroupMoleculesDINsMarketed
G03GBClomifene40

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for CHORIONIC GONADOTROPIN FOR INJECTION, USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02247459. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.